[93] [94] Brazil [edit] In Brazil, the supreme court refused to extend semaglutide's patent protection, which expired in March 2026
Because of this, it is sometimes called a triple agonist
Acceptable limits follow ICH Q3D guidelines for elemental impurities
The critical path: TRIUMPH trials complete (Q2Q3 2026) Data analysis (34 months) NDA submission (Q4 2026 or Q1 2027) FDA review (610 months) Approval (late 2027 or Q1 2028) Launch preparation (13 months) Availability (Q1Q2 2028)
Concerned about hair thinning on Ozempic, Wegovy, or Zepbound
This happens because medication does not address: Stress and emotional eating Poor sleep Low muscle mass Inadequate strength training For peri-menopausal women, repeated cycles of weight loss and regain can worsen bone loss and muscle decline , increasing long-term injury risk